Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Over 68 weeks, with a starting dose of 2 mg escalated every 4 weeks: 9 mg dose: 26.4% average body weight reduction (29.1 kg / 64.2 lbs) 12 mg dose: 28.7% average body weight reduction (32.3 kg / 71.2 lbs) Placebo: 2.1% average body weight reduction The milestone achievements tell an even more compelling story
It is always best to prioritize safety and discard expired vials
Discover the potential of Compounded Semaglutide to support your health journey
Brand reputation: Choose products from providers that can guarantee third-party testing, proper formulation standards, and clinical support
There are eight GLP-1R/GIPR/GCGR agonists under development in the world, of which, Rita's Retatrutide has made the fastest progress and launched the third phase clinical trial in June this year
Ding, Y., Shi, Y., Guan, R., et al
US$ 24.00
US$ 20.42
US$ 28.73
US$ 24.49
